BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Y, White SB, Nicolai JR, Zhang Z, West DL, Kim DH, Goodwin AL, Miller FH, Omary RA, Larson AC. Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model. Radiology. 2014;271:721-729. [PMID: 24555632 DOI: 10.1148/radiol.14130989] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Belfiore MP, De Chiara M, Reginelli A, Clemente A, Urraro F, Grassi R, Belfiore G, Cappabianca S. An overview of the irreversible electroporation for the treatment of liver metastases: When to use it. Front Oncol 2022;12:943176. [DOI: 10.3389/fonc.2022.943176] [Reference Citation Analysis]
2 Eresen A, Sun C, Zhou K, Shangguan J, Wang B, Pan L, Hu S, Ma Q, Yang J, Zhang Z, Yaghmai V. Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI. Acad Radiol 2021:S1076-6332(21)00559-6. [PMID: 34933803 DOI: 10.1016/j.acra.2021.11.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Eresen A, Yang J, Scotti A, Cai K, Yaghmai V, Zhang Z. Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Ann Transl Med 2021;9:1089. [PMID: 34423001 DOI: 10.21037/atm-21-539] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Pan L, Sun C, Zhou K, Figini M, Wang B, Shangguan J, Hu S, Yang J, Xing W, Wang J, Velichko Y, Yaghmai V, Zhang Z. Transcatheter Intraarterial Perfusion MRI Approaches to Differentiate Reversibly Electroporated Penumbra From Irreversibly Electroporated Zones in Rabbit Liver. Acad Radiol 2020;27:1727-33. [PMID: 32033861 DOI: 10.1016/j.acra.2020.01.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu ZG, Chen XH, Yu ZJ, Lv J, Ren ZG. Recent progress in pulsed electric field ablation for liver cancer. World J Gastroenterol 2020; 26(24): 3421-3431 [PMID: 32655266 DOI: 10.3748/wjg.v26.i24.3421] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
6 Chai W, Xie L, Zhao Q, Cheng C, Tian G, Jiang T, Wu P. Ultrasound and Contrast-enhanced Ultrasound Findings after Percutaneous Irreversible Electroporation of Hepatic Malignant Tumors. Ultrasound Med Biol 2020;46:620-9. [PMID: 31924420 DOI: 10.1016/j.ultrasmedbio.2019.12.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Figini M, Zhou K, Pan L, Sun C, Wang B, Hu S, Yang J, Shangguan J, Eresen A, Velichko Y, Yaghmai V, Zhang Z. Transcatheter intra-arterial perfusion (TRIP)-MRI biomarkers help detect immediate response to irreversible electroporation of rabbit VX2 liver tumor. Magn Reson Med. 2020;84:365-374. [PMID: 31850550 DOI: 10.1002/mrm.28104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
8 Hu S, Sun C, Wang B, Zhou K, Pan L, Shangguan J, Yang J, Yaghmai V, Figini M, Zhang Z. Diffusion-Weighted MR Imaging to Evaluate Immediate Response to Irreversible Electroporation in a Rabbit VX2 Liver Tumor Model. J Vasc Interv Radiol. 2019;30:1863-1869. [PMID: 31542271 DOI: 10.1016/j.jvir.2019.05.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Wang X, Su Z, Lyu T, Figini M, Procissi D, Shangguan J, Sun C, Wang B, Shang N, Gu S, Ma Q, Gordon AC, Lin K, Wang J, Lewandowski RJ, Salem R, Yaghmai V, Larson AC, Zhang Z. 18F-FDG PET Biomarkers Help Detect Early Metabolic Response to Irreversible Electroporation and Predict Therapeutic Outcomes in a Rat Liver Tumor Model. Radiology. 2018;287:137-145. [PMID: 29232185 DOI: 10.1148/radiol.2017170920] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
10 Lyu T, Wang X, Su Z, Shangguan J, Sun C, Figini M, Wang J, Yaghmai V, Larson AC, Zhang Z. Irreversible electroporation in primary and metastatic hepatic malignancies: A review. Medicine (Baltimore) 2017;96:e6386. [PMID: 28445252 DOI: 10.1097/MD.0000000000006386] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
11 Sánchez-Velázquez P, Castellví Q, Villanueva A, Iglesias M, Quesada R, Pañella C, Cáceres M, Dorcaratto D, Andaluz A, Moll X, Burdío JM, Grande L, Ivorra A, Burdío F. Long-term effectiveness of irreversible electroporation in a murine model of colorectal liver metastasis. Sci Rep 2017;7:44821. [PMID: 28327623 DOI: 10.1038/srep44821] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Felker ER, Dregely I, Chung DJ, Sung K, Osuagwu FC, Lassman C, Sayre J, Wu H, Lu DS. Irreversible Electroporation: Defining the MRI Appearance of the Ablation Zone With Histopathologic Correlation in a Porcine Liver Model. AJR Am J Roentgenol. 2017;208:1141-1146. [PMID: 28177652 DOI: 10.2214/ajr.16.17207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
13 Barabasch A, Distelmaier M, Heil P, Krämer NA, Kuhl CK, Bruners P. Magnetic Resonance Imaging Findings After Percutaneous Irreversible Electroporation of Liver Metastases: A Systematic Longitudinal Study. Invest Radiol 2017;52:23-9. [PMID: 27379698 DOI: 10.1097/RLI.0000000000000301] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
14 Cho S, Park W, Kim DH. Silica-Coated Metal Chelating-Melanin Nanoparticles as a Dual-Modal Contrast Enhancement Imaging and Therapeutic Agent. ACS Appl Mater Interfaces 2017;9:101-11. [PMID: 27992171 DOI: 10.1021/acsami.6b11304] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
15 Lin MX, Kuang M, Xu M, Zhuang BW, Tian WS, Ye JY, Xie XH, Xie XY. Ultrasound and Contrast-Enhanced Ultrasound for Evaluation of Irreversible Electroporation Ablation: In Vivo Proof of Concept in Normal Porcine Liver. Ultrasound Med Biol. 2016;42:2639-2649. [PMID: 27546157 DOI: 10.1016/j.ultrasmedbio.2016.07.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
16 Bhutiani N, Doughtie CA, Martin RC. Ultrasound validation of mathematically modeled irreversible electroporation ablation areas. Surgery 2016;159:1032-40. [DOI: 10.1016/j.surg.2015.10.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
17 Srimathveeravalli G, Cornelis F, Mashni J, Takaki H, Durack JC, Solomon SB, Coleman JA. Comparison of ablation defect on MR imaging with computer simulation estimated treatment zone following irreversible electroporation of patient prostate. Springerplus 2016;5:219. [PMID: 27026913 DOI: 10.1186/s40064-016-1879-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
18 Anvari A, Barr RG, Dhyani M, Samir AE. Clinical application of sonoelastography in thyroid, prostate, kidney, pancreas, and deep venous thrombosis. Abdom Imaging 2015;40:709-22. [PMID: 25750099 DOI: 10.1007/s00261-015-0383-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
19 Wimmer T, Srimathveeravalli G, Silk M, Monette S, Gutta N, Maybody M, Erinjery JP, Coleman JA, Solomon SB, Sofocleous CT. Feasibility of a Modified Biopsy Needle for Irreversible Electroporation Ablation and Periprocedural Tissue Sampling. Technol Cancer Res Treat 2016;15:749-58. [PMID: 26443800 DOI: 10.1177/1533034615608739] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
20 Makino Y, Imai Y, Igura T, Hori M, Fukuda K, Sawai Y, Kogita S, Fujita N, Takehara T, Murakami T. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma. Abdom Imaging. 2015;40:102-111. [PMID: 25052767 DOI: 10.1007/s00261-014-0201-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
21 Kos B, Voigt P, Miklavcic D, Moche M. Careful treatment planning enables safe ablation of liver tumors adjacent to major blood vessels by percutaneous irreversible electroporation (IRE). Radiol Oncol. 2015;49:234-241. [PMID: 26401128 DOI: 10.1515/raon-2015-0031] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 8.6] [Reference Citation Analysis]
22 Dollinger M, Jung EM, Beyer L, Niessen C, Scheer F, Müller-Wille R, Stroszczynski C, Wiggermann P. Irreversible electroporation ablation of malignant hepatic tumors: subacute and follow-up CT appearance of ablation zones. J Vasc Interv Radiol 2014;25:1589-94. [PMID: 25156648 DOI: 10.1016/j.jvir.2014.06.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]